Enrique Poradosu
Co-Founder, Executive VP, Chief Scientific & Business OfficerDr. Enrique Poradosu, Ph.D. is a Co-Founder at Nuvectis Pharma, Inc. in July 27, 2020 and serves as its Executive Vice President and Chief Scientific & Business Officer since 2020. From 2016 until 2020, he served as SVP, Business and Scientific Strategy at Stemline Therapeutics, Inc. From 1998 until 2003, Dr. Poradosu served as a project manager at a private biomedical incubator. Dr. Poradosu served as Vice President of Scientific & Business Strategy at Keryx Biopharmaceuticals Inc. since 2003 until February 26th 2016. Dr. Poradosu has been with Keryx since 2001. Dr. Poradosu served as a project manager at a private biomedical incubator from 1998 to 2001 involved in identifying technologies and founding and managing start-up companies. Dr. Poradosu holds a BSc in Chemistry and Biology with distinction from the Hebrew University of Jerusalem, Israel and a PhD in Biochemistry, from the Hebrew University of Jerusalem.
公司职务
- 公司名称Nuvectis Pharma, Inc.股票代码NVCT职务Co-Founder, Executive VP, Chief Scientific & Business Officer共事同僚
- RBRon BentsurCo-Founder, Chairman, CEO & President
- SSShay ShemeshCo-Founder, Executive VP, Chief Development & Operations Officer
- MCMichael CarsonVice President of Finance
- KHKenneth HobermanIndependent Director
- JFJames F. OlivieroIndependent Director
- MLMatthew Lee KaplanIndependent Director
- SNShannon N. WestinMember of Scientific Advisory Board
